Skip to main content
SpringerLink
Log in

Comments on the paper “Clinical characteristics and treatment of pars planitis: an adalimumab experience” by Ozdemir et al

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ozdemir HB, Ozdal PC (2021) Clinical characteristics and treatment of pars planitis: an adalimumab experience. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-021-05398-4

    Article  PubMed  Google Scholar 

  2. Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP (2021) Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol 99(6):592–603. https://doi.org/10.1111/aos.14697

    Article  PubMed  Google Scholar 

  3. Kaltsonoudis E, Voulgari PV, Konitsiotis S, Drosos AA (2014) Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev 13(1):54–58. https://doi.org/10.1016/j.autrev.2013.09.002

    Article  CAS  PubMed  Google Scholar 

  4. Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA, International Workshop on Ocular Sarcoidosis Study Group (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103(10):1418–1422. https://doi.org/10.1136/bjophthalmol-2018-313356

    Article  PubMed  Google Scholar 

  5. Niederer RL, Sims JL (2019) Utility of screening investigations for systemic sarcoidosis in undifferentiated uveitis. Am J Ophthalmol 206:149–153. https://doi.org/10.1016/j.ajo.2019.04.012

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Auckland, Auckland, New Zealand

    Francois Pepin & Rachael L. Niederer

Authors
  1. Francois Pepin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachael L. Niederer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francois Pepin.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pepin, F., Niederer, R.L. Comments on the paper “Clinical characteristics and treatment of pars planitis: an adalimumab experience” by Ozdemir et al. Graefes Arch Clin Exp Ophthalmol 260, 2065–2066 (2022). https://doi.org/10.1007/s00417-021-05527-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-021-05527-z

Search

Navigation